All News

Do you think it is time to find a new job or career path? There are 6 signs you should not ignore and encourage you to seek new employment.

What Causes More Opioid Misuse: Higher Doses or Longer Durations?

The FDA has approved iobenguane I-131 (Azedra) for adult and pediatric patients aged ≥12 years with iobenguane scan–positive, unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma (PPGL) who require systemic anticancer therapy.

Sunscreen has been around for a long time.

Federal prosecutors are increasingly turning their attention to pharmacies and pharmacists. In this article, we detail some of the recent enforcement efforts, as well as outline some proactive strategies for compliance.

Officials with the FDA have approved risperidone (Perseris, Indivior) for extended-release injectable suspension for the treatment of schizophrenia in adults.

The FDA has approved the FreeStyle Libre 14-day Flash Glucose Monitoring system, now the longest-lasting self-applied continuous glucose monitor (CGM) in the US market.

Top news of the day from across the health care landscape.

Risperidone (Perseris, Indivior) is the first once-monthly subcutaneous risperidone-containing, long-acting injectable for the treatment of schizophrenia in adults.

Study evaluates doravirine once daily compared with ritonavir-boosted darunavir, each taken in combination with other antiretroviral agents.

Blocking the protein receptor, muscarinic type 3, may be effective in promoting remyelination in patients with multiple sclerosis.

Top news of the day from across the health care landscape.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Summer can be a fun time to explore or vacation at beaches, but what you may not realize is sea lice could be lurking in the ocean.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Use of Truvada (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg) for HIV prevention was associated with a significant decline in new diagnoses across the United States.

Study investigates complementary medicine use in patients with curable cancer types and its impact on survival and adherence to conventional therapy.

Top news of the week from Specialty Pharmacy Times.

As people living with HIV now have a normal life expectancy, the burden of comorbidities is on the rise, and more than half of deaths in the patient population are attributable to the these comorbidities.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Nationwide analysis of Truvada for pre-exposure prophylaxis use finds uptake associated with significant decrease in new HIV infections.

This is Part II in a 2-part series on Verifying Prescriptions.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Study examines the relationship between drinking artificially sweetened beverages and colon cancer disease recurrence and death.